Encompass Health Co. (NYSE:EHC) Position Cut by Swiss National Bank

Swiss National Bank trimmed its holdings in Encompass Health Co. (NYSE:EHCGet Rating) by 0.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 234,300 shares of the company’s stock after selling 1,000 shares during the quarter. Swiss National Bank owned about 0.23% of Encompass Health worth $13,133,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Meeder Asset Management Inc. bought a new position in Encompass Health in the 1st quarter worth approximately $33,000. Worth Asset Management LLC acquired a new stake in Encompass Health in the first quarter worth approximately $35,000. Signaturefd LLC lifted its position in Encompass Health by 106.8% in the first quarter. Signaturefd LLC now owns 1,032 shares of the company’s stock worth $73,000 after purchasing an additional 533 shares during the period. SeaCrest Wealth Management LLC acquired a new stake in Encompass Health in the second quarter worth approximately $85,000. Finally, Covestor Ltd lifted its position in Encompass Health by 157.1% in the first quarter. Covestor Ltd now owns 1,481 shares of the company’s stock worth $105,000 after purchasing an additional 905 shares during the period. 93.07% of the stock is owned by institutional investors.

Insider Activity

In other Encompass Health news, Director Greg D. Carmichael bought 1,830 shares of Encompass Health stock in a transaction dated Monday, October 31st. The stock was bought at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the completion of the acquisition, the director now directly owns 10,546 shares of the company’s stock, valued at $576,549.82. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.70% of the company’s stock.

Encompass Health Price Performance

EHC opened at $56.00 on Friday. The stock has a fifty day moving average of $50.85 and a 200-day moving average of $53.90. The firm has a market capitalization of $5.59 billion, a P/E ratio of 20.59, a PEG ratio of 2.70 and a beta of 1.06. Encompass Health Co. has a 12-month low of $44.33 and a 12-month high of $74.61. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 1.59.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be issued a $0.15 dividend. The ex-dividend date is Friday, December 30th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.07%. Encompass Health’s payout ratio is currently 22.06%.

Analyst Ratings Changes

EHC has been the subject of a number of research analyst reports. Royal Bank of Canada cut their target price on Encompass Health from $82.00 to $66.00 in a research report on Wednesday, August 24th. BMO Capital Markets cut their target price on Encompass Health from $83.00 to $65.00 and set an “outperform” rating for the company in a research report on Thursday, August 4th. Stephens cut their target price on Encompass Health from $60.00 to $58.00 and set an “overweight” rating for the company in a research report on Friday, October 28th. Truist Financial cut their price objective on Encompass Health from $75.00 to $65.00 and set a “buy” rating for the company in a research report on Monday, August 8th. Finally, Raymond James increased their price objective on Encompass Health from $65.00 to $72.00 and gave the company a “strong-buy” rating in a research report on Friday, October 28th. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Encompass Health presently has an average rating of “Buy” and an average price target of $64.13.

Encompass Health Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Articles

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.